Acknowledgments
We thank ARK™ Diagnostics for providing VRC Immunoassay Reagent, Calibrators and Controls needed for evaluation free of charge.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Financial support: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003;36:630–7.10.1086/367933Search in Google Scholar PubMed
2. Website (EMEA). EMA. EPAR – Product information for Vfend. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000387/WC500049756.pdf. Accessed June 17, 2014.Search in Google Scholar
3. Website (EMEA) EMA. CHMP – Summary of opinion for Vfend. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/000387/WC500167427.pdf. Accessed June 17, 2014.Search in Google Scholar
4. Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother 2014;69:1162–76.10.1093/jac/dkt508Search in Google Scholar PubMed PubMed Central
5. Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 2008;46:201–11.10.1086/524669Search in Google Scholar PubMed
6. Pascual A, Csajka C, Buclin T, Bolay S, Bille J, Calandra T, et al. Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. Clin Infect Dis 2012;55:381–90.10.1093/cid/cis437Search in Google Scholar PubMed
7. Trifilio SM, Yarnold PR, Scheetz MH, Pi J, Pennick G, Mehta J. Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation. Antimicrob Agents Chemother 2009;53:1793–6.10.1128/AAC.01316-08Search in Google Scholar PubMed PubMed Central
8. Steinmann J, Huelsewede J, Buer J, Rath PM. Comparison and evaluation of a novel bioassay and high-performance liquid chromatography for the clinical measurement of serum voriconazole concentrations. Mycoses 2011;54:e421–8.10.1111/j.1439-0507.2010.01938.xSearch in Google Scholar PubMed
9. Cendejas-Bueno E, Cuenca-Estrella M, Gomez-Lopez A. Determination of voriconazole serum concentration by bioassay, a valid method for therapeutic drug monitoring for clinical laboratories. Antimicrob Agents Chemother 2013;57:3437–40.10.1128/AAC.00323-13Search in Google Scholar PubMed PubMed Central
10. Pascual A, Nieth V, Calandra T, Bille J, Bolay S, Decosterd LA, et al. Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods. Antimicrob Agents Chemother 2007;51:137–43.10.1128/AAC.00957-06Search in Google Scholar PubMed PubMed Central
11. Perea S, Pennick GJ, Modak A, Fothergill AW, Sutton DA, Sheehan DJ, et al. Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. Antimicrob Agents Chemother 2000;44:1209–13.10.1128/AAC.44.5.1209-1213.2000Search in Google Scholar PubMed PubMed Central
12. Zhang M, Moore GA, Barclay ML, Begg EJ. A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma. Antimicrob Agents Chemother 2013;57:484–9.10.1128/AAC.00768-12Search in Google Scholar PubMed PubMed Central
13. Yamada T, Mino Y, Yagi T, Naito T, Kawakami J. Rapid simultaneous determination of voriconazole and its N-oxide in human plasma using an isocratic high-performance liquid chromatography method and its clinical application. Clin Biochem 2012;45:134–8.10.1016/j.clinbiochem.2011.11.004Search in Google Scholar PubMed
14. Langman LJ, Boakye-Agyeman F. Measurement of voriconazole in serum and plasma. Clin Biochem 2007;40:1378–85.10.1016/j.clinbiochem.2007.07.024Search in Google Scholar PubMed
15. Wissen CP, Burger DM, Verweij PE, Aarnoutse RE, Bruggemann RJ. Simultaneous determination of the azoles voriconazole, posaconazole, isavuconazole, itraconazole and its metabolite hydroxy-itraconazole in human plasma by reversed phase ultra-performance liquid chromatography with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 2012;887–888:79–84.10.1016/j.jchromb.2012.01.015Search in Google Scholar PubMed
16. Michael C, Teichert J, Preiss R. Determination of voriconazole in human plasma and saliva using high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2008;865:74–80.10.1016/j.jchromb.2008.02.009Search in Google Scholar PubMed
17. Gordien JB, Pigneux A, Vigouroux S, Tabrizi R, Accoceberry I, Bernadou JM, et al. Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal 2009;50:932–8.10.1016/j.jpba.2009.06.030Search in Google Scholar PubMed
18. Mistretta V, Dubois N, Denooz R, Charlier C. Simultaneous determination of seven azole antifungal drugs in serum by ultra-high pressure liquid chromatography and diode array detection. Acta Clin Belg 2014;69:53–61.10.1179/0001551213Z.00000000018Search in Google Scholar PubMed
19. Kahle K, Langmann P, Schirmer D, Lenker U, Keller D, Helle A, et al. Simultaneous determination of voriconazole and posaconazole concentrations in human plasma by high-performance liquid chromatography. Antimicrob Agents Chemother 2009;53:3140–2.10.1128/AAC.00213-09Search in Google Scholar PubMed PubMed Central
20. Egle H, Trittler R, Konig A, Kummerer K. Fast, fully automated analysis of voriconazole from serum by LC-LC-ESI-MS-MS with parallel column-switching technique. J Chromatogr B Analyt Technol Biomed Life Sci 2005;814:361–7.10.1016/j.jchromb.2004.10.069Search in Google Scholar PubMed
21. Verdier MC, Bentue-Ferrer D, Tribut O, Bellissant E. Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma. Clin Chem Lab Med 2010;48:1515–22.10.1515/CCLM.2010.252Search in Google Scholar PubMed
22. Lin D, Li G, Chen L. Determination of voriconazole in human plasma by HPLC-ESI-MS and application to pharmacokinetic study. J Chromatogr Sci 2013;51:485–9.10.1093/chromsci/bms178Search in Google Scholar PubMed
23. Baietto L, D’Avolio A, Ventimiglia G, De Rosa FG, Siccardi M, Simiele M, et al. Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma. Antimicrob Agents Chemother 2010;54:3408–13.10.1128/AAC.01807-09Search in Google Scholar PubMed PubMed Central
24. Chahbouni A, Wilhelm AJ, den Burger JC, Sinjewel A, Vos RM. Validated liquid chromatography-tandem mass spectroscopy method for the simultaneous quantification of four antimycotic agents in human serum. Ther Drug Monit 2010;32:453–7.10.1097/FTD.0b013e3181e185fdSearch in Google Scholar PubMed
25. Beste KY, Burkhardt O, Kaever V. Rapid HPLC-MS/MS method for simultaneous quantitation of four routinely administered triazole antifungals in human plasma. Clin Chim Acta 2012;413:240–5.10.1016/j.cca.2011.09.042Search in Google Scholar PubMed
26. Pauwels S, Vermeersch P, Van Eldere J, Desmet K. Fast and simple LC-MS/MS method for quantifying plasma voriconazole. Clin Chim Acta 2012;413:740–3.10.1016/j.cca.2012.01.008Search in Google Scholar PubMed
27. Keevil BG, Newman S, Lockhart S, Howard SJ, Moore CB, Denning DW. Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2004;26:650–7.10.1097/00007691-200412000-00011Search in Google Scholar PubMed
28. Alffenaar JW, Wessels AM, van Hateren K, Greijdanus B, Kosterink JG, Uges DR. Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:39–44.10.1016/j.jchromb.2009.11.017Search in Google Scholar PubMed
29. Decosterd LA, Rochat B, Pesse B, Mercier T, Tissot F, Widmer N, et al. Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin. Antimicrob Agents Chemother 2010;54:5303–15.10.1128/AAC.00404-10Search in Google Scholar PubMed PubMed Central
30. Lempers VJ, Alffenaar JW, Touw DJ, Burger DM, Uges DR, Aarnoutse RE, et al. Five year results of an international proficiency testing programme for measurement of antifungal drug concentrations. J Antimicrob Chemother 2014. DOI:10.1093/jac/dku242.10.1093/jac/dku242Search in Google Scholar PubMed
Supplemental Material
The online version of this article (DOI: 10.1515/cclm-2014-0774) offers supplementary material, available to authorized users.
©2015 by De Gruyter